UB Paderborn / Katalog / Suche / in CDI

26 – 50 von 174

Sortiert nach

Assessment of Total Lesion Glycolysis by 18F FDG PET/CT Significantly Improves Prognostic Value of GEP and ISS in Myeloma

Clinical cancer research, 2017-04, Vol.23 (8), p.1981-1987

2017

Volltextzugriff (PDF)

Meningeosis myelomatosis

Blood, 2020-09, Vol.136 (12), p.1466-1466

2020

Volltextzugriff (PDF)

Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission

Journal of clinical medicine, 2022-03, Vol.11 (6), p.1640

2022

Volltextzugriff (PDF)

Enterococcus raffinosus infection with atypical hemolytic uremic syndrome in a multiple myeloma patient after autologous stem cell transplant

Hematology reports, 2017-09, Vol.9 (3), p.7094-7094

2017

Volltextzugriff (PDF)

3195 Genomic Analysis of Primary Plasma Cell Leukemia reveals Complex Cytogenetic Alterations and High Risk Mutational Patterns

Journal of clinical and translational science, 2019-03, Vol.3 (s1), p.11-12

2019

Volltextzugriff (PDF)

Ethnic Disparities in AL Amyloidosis Outcomes Among Hospitalized Patients in the United States

Blood, 2021-11, Vol.138 (Supplement 1), p.4110-4110

2021

Volltextzugriff (PDF)

Enrollment of Black Americans in Pivotal Clinical Trials Supporting Food and Drug Administration (FDA) Chimeric Antigen Receptor (CAR)-T Cell Therapy Approval in Hematological Malignancies

Blood, 2021-11, Vol.138 (Supplement 1), p.566-566

2021

Volltextzugriff (PDF)

Clinical Research Focused on Supportive Care in Multiple Myeloma: A Cross Sectional Analysis

Blood, 2022-11, Vol.140 (Supplement 1), p.13240-13241

2022

Volltextzugriff (PDF)

Under-Representation of Black Patients with Multiple Myeloma in Studies Supporting International Myeloma Working Group Guidelines

Blood, 2022-11, Vol.140 (Supplement 1), p.13212-13213

2022

Volltextzugriff (PDF)

New adoptive immunotherapy strategies for solid tumours with CIK cells

Expert opinion on biological therapy, 2012-05, Vol.12 (5), p.565-572

2012

Volltextzugriff (PDF)

Severe right-sided heart failure and pulmonary hypertension with carfilzomib treatment in multiple myeloma

Heart views, 2020-10, Vol.21 (4), p.296-299

2020

Volltextzugriff (PDF)

CLO24-090: Demographics and Outcomes of Autologous Stem Cell Transplant Among IgD Multiple Myeloma Patients

Journal of the National Comprehensive Cancer Network, 2024-04, Vol.22 (2.5)

2024

Volltextzugriff (PDF)

Richter Syndrome and Brain Involvement: Low-Grade Lymphoma Relapsing as Cerebral High-Grade Lymphoma

Acta haematologica, 2012-01, Vol.127 (2), p.93-95

2012

Volltextzugriff (PDF)

Risk of infections associated with the use of bispecific antibodies in multiple myeloma: a pooled analysis

Blood advances, 2023-07, Vol.7 (13), p.3069-3074

2023

Volltextzugriff (PDF)

The Use and Reporting of Cytogenetics in Phase III Multiple Myeloma Clinical Trials

Blood, 2022-11, Vol.140 (Supplement 1), p.12532-12533

2022

Volltextzugriff (PDF)

Variability of Definition of High-Risk Multiple Myeloma in Phase III Clinical Trials

Blood, 2022-11, Vol.140 (Supplement 1), p.10116-10117

2022

Volltextzugriff (PDF)

Risk of Infections Associated with the Use of Bispecific Antibodies in Multiple Myeloma: A Pooled Analysis

Blood, 2022-11, Vol.140 (Supplement 1), p.4378-4378

2022

Volltextzugriff (PDF)

BCMA- and CST6-specific CAR T cells lyse multiple myeloma cells and suppress murine osteolytic lesions

The Journal of clinical investigation, 2024-01, Vol.134 (1), p.1-13

2024

Volltextzugriff (PDF)

First‐ versus second‐generation Bruton tyrosine kinase inhibitors in Waldenström's Macroglobulinemia: A systematic review and meta‐analysis

American journal of hematology, 2022-07, Vol.97 (7), p.942-950

2022

Volltextzugriff (PDF)

Deep Profiling of the Immune Microenvironment throughout Myeloma Disease Stages

Blood, 2021-11, Vol.138 (Supplement 1), p.727-727

2021

Volltextzugriff (PDF)

Concomitant Deletion of Short Arm (del 1p) and Amplification or Gain (1q21) of Chromosome 1 By Fluorescence in Situ Hybridization (FISH) Is Associated with Poor Clinical Outcome

Blood, 2021-11, Vol.138 (Supplement 1), p.1627-1627

2021

Volltextzugriff (PDF)

Curability of multiple myeloma (MM) based on relative survival rate (RSR) in patients (pts) treated on earlier total therapy (TT) protocols

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.8059-8059

2023

Volltextzugriff (PDF)

Three years (yrs) maintenance with bortezomib, lenalidomide, and dexamethasone (RVD) in multiple myeloma (MM): Results of Total Therapy (TT) IIIB

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e20053-e20053

2023

Volltextzugriff (PDF)

Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy

Bone marrow transplantation (Basingstoke), 2023-04, Vol.58 (4), p.443-445

2023

Volltextzugriff (PDF)

26 – 50 von 174

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(168)
Mit Volltextzugriff
(170)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Assessment of Total Lesion Glycolysis by 18F FDG PET/CT Significantly Improves Prognostic Value of GEP and ISS in Myeloma

Meningeosis myelomatosis

Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission

Enterococcus raffinosus infection with atypical hemolytic uremic syndrome in a multiple myeloma patient after autologous stem cell transplant

3195 Genomic Analysis of Primary Plasma Cell Leukemia reveals Complex Cytogenetic Alterations and High Risk Mutational Patterns

Low expression of hexokinase-2 is associated with false-negative FDG–positron emission tomography in multiple myeloma

Ethnic Disparities in AL Amyloidosis Outcomes Among Hospitalized Patients in the United States

Enrollment of Black Americans in Pivotal Clinical Trials Supporting Food and Drug Administration (FDA) Chimeric Antigen Receptor (CAR)-T Cell Therapy Approval in Hematological Malignancies

Clinical Research Focused on Supportive Care in Multiple Myeloma: A Cross Sectional Analysis

Under-Representation of Black Patients with Multiple Myeloma in Studies Supporting International Myeloma Working Group Guidelines

New adoptive immunotherapy strategies for solid tumours with CIK cells

Severe right-sided heart failure and pulmonary hypertension with carfilzomib treatment in multiple myeloma

CLO24-090: Demographics and Outcomes of Autologous Stem Cell Transplant Among IgD Multiple Myeloma Patients

Richter Syndrome and Brain Involvement: Low-Grade Lymphoma Relapsing as Cerebral High-Grade Lymphoma

Risk of infections associated with the use of bispecific antibodies in multiple myeloma: a pooled analysis

The Use and Reporting of Cytogenetics in Phase III Multiple Myeloma Clinical Trials

Variability of Definition of High-Risk Multiple Myeloma in Phase III Clinical Trials

Risk of Infections Associated with the Use of Bispecific Antibodies in Multiple Myeloma: A Pooled Analysis

BCMA- and CST6-specific CAR T cells lyse multiple myeloma cells and suppress murine osteolytic lesions

First‐ versus second‐generation Bruton tyrosine kinase inhibitors in Waldenström's Macroglobulinemia: A systematic review and meta‐analysis

Deep Profiling of the Immune Microenvironment throughout Myeloma Disease Stages

Concomitant Deletion of Short Arm (del 1p) and Amplification or Gain (1q21) of Chromosome 1 By Fluorescence in Situ Hybridization (FISH) Is Associated with Poor Clinical Outcome

Curability of multiple myeloma (MM) based on relative survival rate (RSR) in patients (pts) treated on earlier total therapy (TT) protocols

Three years (yrs) maintenance with bortezomib, lenalidomide, and dexamethasone (RVD) in multiple myeloma (MM): Results of Total Therapy (TT) IIIB

Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy

Suchergebnisse filtern